The latest news from India's most respected business daily.Business StandardThe shares of Strides Arcolab (Strides) surged by 17 per cent to Rs 172.05 after Onco Therapies (OTL), the joint venture between Strides and Aspen Pharmacare Holdings, concluded a licensing and supply agreement with GlaxoSmithKline (GSK).
[visit website]
Sections
Newsletter
